![OB GYN new masthead 1](https://prodcraftsa01.blob.core.windows.net/assets/products/ob-gyn-clinical-alert/_contentImage/OB_GYN_new_masthead_1.png)
OB/GYN Clinical Alert – August 1, 2011
August 1, 2011
View Issues
-
Progestins and Risk of Venous Thromboembolism: What's the Deal with Drospirenone?
Two independent case-control studies investigating the risk of venous thromboembolism (VTE) in users of oral contraceptives (OC) containing 30 mcg of ethinyl estradiol and a progestin component of either drospirenone or levonorgestrel found that VTE risk was two to three times higher in those using a drospirenone pill. -
Term Pregnancy
The concept that "term" pregnancy applies to any pregnancy extending past 36 completed weeks has been recently strongly challenged. -
What To Do About Microscopic Hematuria
This case-driven discussion of microscopic hematuria includes important guidelines, definitions, and reminders to aid the clinician in managing this common finding. -
Is it Time to Change the Standard of Care for Low-risk GTN?
There are at least six different commonly used chemotherapeutic regimens in practice to treat patients with low-risk gestational trophoblastic neoplasia (GTN) with no consensus or previous formal evaluation as to which may be best. -
Pharmacology Watch: FDA issues Multiple Drug Warnings
In this issue: FDA issues multiple drug safety alerts; ARBs and cancer risk; and FDA actions. -
Clinical Briefs in Primary Care supplement